Quick Answer
China SXT Pharmaceuticals, Inc. reported Total Assets of $21.66 million for fiscal year 2025.
China SXT Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $21.66M | -6.3% |
| 2024 | $23.13M | -21.7% |
| 2023 | $29.55M | -11.9% |
| 2022 | $33.55M | -2.9% |
| 2021 | $34.55M | +59.2% |
| 2020 | $21.70M | +24.2% |
| 2019 | $17.47M | +128.1% |
| 2018 | $7.66M | — |
- China SXT Pharmaceuticals, Inc. showed a decrease of -6.3% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, China SXT Pharmaceuticals, Inc.’s total assets has grown by 182.9% (from $7.66 million to $21.66 million).
- The most recent figure is from China SXT Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 20-F), filed with the SEC on July 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: